1. ᅟ

   Acknowledgement to Referees 03 December 2016 Pages: 701 - 704

2. Annual Congress of the European Society for Medical Oncology (ESMO): Copenhagen, Denmark; 7–11 October 2016

   • Martin Chopra

   Meeting Report 04 November 2016 Pages: 705 - 709

3. Will Testicular Germ Cell Tumors Remain Untargetable?

   • Fouad Aoun
   • Hampig Raphael Kourie
   • Thierry Roumeguère

   Review Article 17 May 2016 Pages: 711 - 721

4. Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development

   • Juan Wang
   • Guixiang Tai

   Review Article 08 July 2016 Pages: 723 - 738

   

5. Anti-EGFR Agents: Current Status, Forecasts and Future Directions

   • Radoslaw Kwapiszewski
   • Sebastian D. Pawlak
   • Karolina Adamkiewicz

   Review Article 11 August 2016 Pages: 739 - 752

   

6. Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis

   • Xue Li
   • Minghuan Li
   • Jinming Yu

   Systematic Review 15 July 2016 Pages: 753 - 761

   

7. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines

   • Weiya Z. Wysham
   • Dario R. Roque
   • Victoria L. Bae-Jump

   Original Research Article 18 May 2016 Pages: 763 - 769

   

8. Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines

   • Cong Wang
   • Qin Yan
   • Zhenqing Feng

   Original Research Article 02 June 2016 Pages: 771 - 781

   

9. Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines

   • Maria Pinkerneil
   • Michèle J. Hoffmann
   • Günter Niegisch

   Original Research Article Open access 02 June 2016 Pages: 783 - 798

   

10. Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05)

    • Akihito Tsuji
    • Yu Sunakawa
    • Toshifusa Nakajima

    Original Research Article 15 June 2016 Pages: 799 - 806

    

11. Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors

    • Monica M. Mita
    • John Nemunaitis
    • Vincent Strout

    Original Research Article 25 July 2016 Pages: 807 - 814

12. Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial

    • Aaron Vinik
    • Andrew Bottomley
    • Eric Raymond

    Original Research Article 06 December 2016 Pages: 815 - 824

    

13. Afatinib: A Review in Advanced Non-Small Cell Lung Cancer

    • Gillian M. Keating

    Adis Drug Evaluation 22 November 2016 Pages: 825 - 835

    

14. Retraction Note to: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials

    • Jin Liu
    • Zhixin Sheng
    • Guixin Li

    Retraction Note 29 November 2016 Pages: 837 - 837

15. Retraction Note to: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8

    • Ying Wang
    • Po Xu
    • Shegan Gao

    Retraction Note 05 December 2016 Pages: 839 - 839